Belgium’s Deputy Prime Minister, Kris Peeters, presented eight companies with awards to recognise their commitment to hiring people with MS
MSIF is proud to announce the recipients of the 2017 McDonald fellowships and Du Pre grants
New Support Line will provide information and support, as well as jobs for people living with MS
The EMA has recommended that ocrelizumab (Ocrevus), the first disease-modifying treatment for primary progressive MS (PPMS), be prescribed for adults with early primary progressive MS
Scientists have been using a large database to develop algorithms to predict individual responses to a particular therapy before starting it.
A new small study has discovered molecules in the blood that are specific to people with MS, and can distinguish between relapsing remitting and progressive MS.
Researchers have been trialling low current electric brain stimulation as a way to help manage MS related fatigue.
Anti-histamine drug clemastine may boost myelin repair in MS
MSIF’s Capacity Building Manager visits Arfa MS Society to launch MSIF’s new country-focused programme in the Kingdom of Saudi Arabia.
The MS Society of India (MSSI) is proud to congratulate Dr Rebecca Verghese, a long-standing volunteer with the society who lives with MS, in winning an award at the “Mrs India Earth” pageant.
Multiple Sclerosis Argentina (EMA) has launched a brand new website and YouTube channel in order to increase its reach to people affected by MS.
The Polish MS Society’s annual awareness-raising campaign, “Symphony of Hearts”, has entered its tenth year